Loading clinical trials...
Loading clinical trials...
Cirrhosis is associated with a reduction in muscle mass and exercise capacity. This has an impact or morbidity and mortality. Regular aerobic exercise training is a proven effective therapy to improve...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alberta
NCT07280390 · Cirrhosis, Microplastics, and more
NCT06345547 · Sarcopenia, Cirrhosis, and more
NCT07069725 · Liver Fibrosis, Hepatic Cirrhosis
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more
University of Alberta, Mazankowski Heart Institute
Edmonton, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions